Every material Form 8-K Parsons filed with the SEC in 2025, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Parsons Corporation appointed John T. Martinez as its Chief Legal Officer, effective February 16, 2026, succeeding Michael R. Kolloway, who has held the role since 2017 and plans to retire in the second quarter of 2026. Martinez brings more than 25 years of legal experience, including prior chief legal officer and general counsel roles at Maximus, GE Aerospace and Raytheon Technologies subsidiaries.
John T. Martinez named Chief Legal Officer, effective February 16, 2026
Predecessor Michael R. Kolloway has served as CLO since 2017 and will remain as an advisor until retirement in Q2 2026
Martinez previously served as chief legal officer and corporate secretary at Maximus, Inc. and vice president and general counsel at GE Aerospace
Parsons Corporation's board elected Robert H. Smith as a director effective December 1, 2025, and increased the board size to 12 members. Smith, former CEO of Blue Origin, joins as a Class I director with a term expiring at the 2026 annual meeting. The filing describes the appointment as adding relevant aerospace and government experience, though it gives no financial figures.
Robert H. Smith elected to the board effective December 1, 2025, as a Class I director
Board size increased to 12 members; term expires at the 2026 annual meeting of stockholders
Smith was CEO of Blue Origin from 2017 through January 2024 and has served on Parsons' Strategic Advisory Board since April 2024
Smith will receive cash and equity compensation under the non-employee director policy
Parsons reported third quarter 2025 revenue of $1.6 billion, down 10% from a year earlier, and net income attributable to Parsons of $64 million, down from $72 million. The company lowered its fiscal 2025 revenue guidance, while reiterating its adjusted EBITDA and operating cash flow ranges at the mid-point, which matters to shareholders because the lower revenue outlook signals weaker top-line expectations for the year.
Q3 2025 revenue was $1.6 billion, down 10% year over year and down 14% on an organic basis.
Q3 GAAP diluted EPS was $0.59, compared with $0.65 in the prior year period.
Fiscal 2025 revenue guidance is now $6,400 million to $6,500 million, down from $6,480 million to $6,680 million; adjusted EBITDA ($600 million to $630 million) and operating cash flow ($380 million to $460 million) ranges were reiterated a
Total backlog was $8.8 billion at September 30, 2025, with a book-to-bill ratio of 1.0x for the quarter.
Parsons reported second-quarter 2025 results on August 6, 2025, with revenue down 5% year-over-year and net income attributable to Parsons down 20% to $55 million. The company raised its fiscal 2025 guidance ranges for revenue, adjusted EBITDA and cash flow from operations, and reported total backlog of $8.9 billion. For shareholders, weaker quarterly profit and revenue sit alongside a higher full-year outlook.
Q2 2025 revenue was $1.6 billion, down 5% year-over-year and down 9% on an organic basis.
Net income attributable to Parsons was $55 million, versus $69 million a year earlier; diluted EPS was $0.50 versus $0.63.
Adjusted EBITDA was $149 million, down 1%, while adjusted EBITDA margin rose 40 basis points to 9.4%.
Fiscal 2025 revenue guidance was raised to $6,480 million-$6,680 million from $6,450 million-$6,650 million.
Parsons entered into a $450 million unsecured term loan and a $750 million unsecured revolving credit facility on June 5, 2025, with Bank of America as administrative agent. The new term loan paid off a $350 million delayed draw term loan, and the new revolver replaced the 2021 revolving credit agreement, which was paid off in full, so the company's borrowing terms are refreshed ahead of older maturities. The filing does not report revenue, profit, or guidance, so it does not show direct effects on operating results.
$450 million term loan, three-year maturity, no required amortization; initial rate set at the middle of a Term SOFR plus 0.875% to 1.500% range
$750 million revolver, five-year maturity, with no amounts funded at closing; initial rate set at the middle of a Term SOFR plus 1.00% to 1.625% range
Proceeds used to repay the $350 million 2022 delayed draw term loan and the 2021 revolver, with remaining amounts available for working capital and general corporate purposes
Parsons reported first-quarter 2025 results, with revenue up 1% to $1.6 billion and GAAP diluted EPS of $0.60, compared with $0.37 a year earlier. The company reiterated its fiscal 2025 guidance ranges for revenue, adjusted EBITDA and operating cash flow. Organic revenue fell 2% and operating cash flow was negative $12 million, so the profit gains are the main positive for shareholders.
Revenue of $1.6 billion rose $19 million, or 1%, year over year, and fell 2% on an organic basis.
Net income attributable to Parsons was $66 million, up from $40 million; diluted EPS was $0.60 versus $0.37.
Adjusted EBITDA was $149 million, up 5%; adjusted EPS was $0.78 versus $0.70.
Fiscal 2025 guidance reiterated: revenue of $7.0 billion to $7.5 billion and adjusted EBITDA of $640 million to $710 million.
Parsons reported record fourth-quarter and full-year 2024 results, with full-year revenue of $6.8 billion, up 24%, and net income attributable to Parsons of $235 million, up 46%. The company also issued fiscal 2025 guidance of $7.0 billion to $7.5 billion in revenue and $640 million to $710 million in adjusted EBITDA, which gives shareholders a benchmark for the year ahead.
Q4 2024 revenue rose 16% to $1.7 billion, and net income rose 21% to $54 million
Q4 adjusted EBITDA margin was 8.5%, versus 8.6% a year earlier, after $29 million of adjustments on two programs
FY2025 guidance: revenue $7.0 billion to $7.5 billion; adjusted EBITDA $640 million to $710 million; operating cash flow $420 million to $480 million
Full-year 2024 operating cash flow was $524 million, up 28%
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every Parsons filing is on SEC EDGAR ↗. 8-K briefs of other companies →